Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 1/20 | 0.62 |
| ▸ | MTOR | P42345 | 1/20 | 0.62 |
| ▸ | JAK2 | O60674 | 17/20 | 0.60 |
| ▸ | JAK1 | P23458 | 17/20 | 0.60 |
| ▸ | AURKA | O14965 | 1/20 | 0.60 |
| ▸ | PRKCA | P17252 | 1/20 | 0.60 |
| ▸ | KDR | P35968 | 1/20 | 0.60 |
| ▸ | JAK3 | P52333 | 3/20 | 0.56 |
| ▸ | RET | P07949 | 1/20 | 0.56 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.56 |
| ▸ | LTK | P29376 | 1/20 | 0.56 |
| ▸ | GRK5 | P34947 | 1/20 | 0.56 |
| ▸ | BTK | Q06187 | 1/20 | 0.56 |
| ▸ | MAP4K2 | Q12851 | 1/20 | 0.56 |
| ▸ | STK33 | Q9BYT3 | 1/20 | 0.56 |
| ▸ | TYK2 | P29597 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24945774 | 0.83 | JAK3 (0.55) | PIK3CAMTORJAK2JAK1AURKA | |
| SCHEMBL17122716 | 0.83 | JAK3 (0.58) | PIK3CAMTORJAK2JAK1AURKA | |
| SCHEMBL12032395 | 0.82 | JAK3 (0.64) | PIK3CAMTORJAK2JAK1AURKA | |
| SCHEMBL25068859 | 0.81 | JAK1 (0.54) | JAK2JAK1AURKAPRKCAKDR | |
| SCHEMBL20290048 | 0.81 | JAK3 (0.53) | JAK2JAK1AURKAPRKCAKDR | |
| SCHEMBL18855755 | 0.80 | JAK1 (0.61) | PIK3CAMTORJAK2JAK1AURKA | |
| SCHEMBL12385427 | 0.79 | JAK2 (0.90) | PIK3CAJAK2JAK1AURKAPRKCA | |
| SCHEMBL20289826 | 0.79 | JAK1 (0.56) | JAK2JAK1AURKAPRKCAKDR | |
| SCHEMBL20289715 | 0.77 | JAK3 (0.47) | PIK3CAMTORJAK2JAK1AURKA | |
| SCHEMBL30849428 | 0.77 | PIK3CA (1.00) | PIK3CAMTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018153-A1 | BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF | 2692372 ONTARIO, INC. (CA) | 2024-01-18 | — | — | US | disclosed |
| WO-2022106902-A2 | BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF | 2692372 ONTARIO, INC. (CA) | 2022-05-27 | — | — | WO | disclosed |
| WO-2021099842-A1 | PENTAFLUOROBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF | 2692372 ONTARIO INC. (CA) | 2021-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018153-A1 | BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF | ABCG2, ABCB1, ARSA | PIK3CA 1582/4885MTOR 1396/4885JAK2 125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.